The Substance Abuse and Mental Health Services Administration today postponed the effective date of its final rule on confidentiality of substance use disorder patient records to March 21. The Office of Management and Budget last month published a memorandum calling for heads of executive departments and agencies to postpone for review for 60 days most regulations that have been published in the Federal Register but not yet taken effect. For those regulations that “raise substantial questions of law or policy,” the memorandum calls for agencies to “take further appropriate action in consultation with the OMB director.” AHA had urged SAMHSA to align the final rule, the first major update to the confidentiality rule since 1987, with the Health Insurance Portability and Accountability Act.

Related News Articles

Blog
Public
Medical residency is one of the most demanding stages in a physician’s career. Long hours, intense learning and new responsibilities often push trainees to…
Headline
A Gallup report published Sept. 9 found that nearly 48 million Americans currently have or are being treated for depression. The total, which equals 18.3% of…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Blog
In this insightful conversation hosted by Nancy Myers of the American Hospital Association, we explore how Owensboro Health (Ky.) and CredibleMind are…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…